Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content



2014-12-18@04:24:53 ET
Malaria - Pipeline Review, H1 2014 (MTO)

2014-12-16@08:00:00 ET
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer (PRN)

2014-12-15@05:14:22 ET
Genzyme initiates treatment of first patients in multiple sclerosis study (DTM)

2014-12-03@08:38:10 ET
Fabry Disease - Pipeline Review, H2 2014 (MTO)

2014-11-21@10:36:34 ET
North America Wound Closure Devices Market Outlook to 2020 (MTO)

2014-11-10@07:00:16 ET
James M. DeTore joins bluebird bio as Chief Financial Officer (BIZ)

2014-11-07@11:05:20 ET
U-Michigan signs royalty agreement for Gaucher disease drug (UNW)

2014-10-27@07:30:22 ET
Exact Sciences Reports Third-Quarter 2014 Financial Results (BIZ)

2014-10-27@01:40:24 ET
iTraumaCare Appoints Joseph Brennan as President and CEO (CLM)

2014-10-22@09:56:28 ET
Genzyme receives FDA approval for label update of multiple sclerosis drug (DTM)

2014-10-22@06:44:29 ET
Global RNA Based Therapeutics Market 2014-2020: Market to Grow at CAGR of 28% and Reach $1.2 Billion in 2020 (MTO)

2014-10-20@09:09:01 ET
United States Wound Closure Devices Market Outlook 2020: Key Players are Johnson & Johnson, Baxter International & Pfizer (MTO)

2014-10-02@06:03:15 ET
Thyroid Cancer Market Analysis - API Manufacturers and Phase III Pipeline Assessment 2014-2015 (MTO)

2014-09-29@08:17:01 ET
Dr. Alan E. Smith, Former Chief Scientific Officer of Genzyme, Joins ImmuneXcite's Scientific Advisory Board (BIZ)

2014-09-17@12:19:30 ET
US Patent Issued to Genzyme on Sept. 16 for "Oligosaccharide-protein conjugates" (American, Swiss Inventors) (ABW)

2014-09-12@04:29:47 ET
Spinal Muscular Atrophy (SMA) Therapeutics Pipeline Review 2014 - 17 Companies & 27 Drug Profiles (MTO)